Literature DB >> 16603186

Structural insights of the specificity and catalysis of a viral histone H3 lysine 27 methyltransferase.

Chengmin Qian1, Xueqi Wang, Karishma Manzur, Amjad Farooq, Lei Zeng, Rong Wang, Ming-Ming Zhou.   

Abstract

SET domain lysine methyltransferases are known to catalyze site and state-specific methylation of lysine residues in histones that is fundamental in epigenetic regulation of gene activation and silencing in eukaryotic organisms. Here we report the three-dimensional solution structure of the SET domain histone lysine methyltransferase (vSET) from Paramecium bursaria chlorella virus 1 bound to cofactor S-adenosyl-L-homocysteine and a histone H3 peptide containing mono-methylated lysine 27. The dimeric structure, mimicking an enzyme/cofactor/substrate complex, yields the structural basis of the substrate specificity and methylation multiplicity of the enzyme. Our results from mutagenesis and enzyme kinetics analyses argue that a general base mechanism is less likely for lysine methylation by SET domains; and that the only invariant active site residue tyrosine 105 in vSET facilitates methyl transfer from cofactor to the substrate lysine by aligning intermolecular interactions in the lysine access channel of the enzyme.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16603186     DOI: 10.1016/j.jmb.2006.03.006

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  28 in total

1.  Dimerization of a viral SET protein endows its function.

Authors:  Hua Wei; Ming-Ming Zhou
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-11       Impact factor: 11.205

2.  Ab initio quantum mechanical/molecular mechanical molecular dynamics simulation of enzyme catalysis: the case of histone lysine methyltransferase SET7/9.

Authors:  Shenglong Wang; Po Hu; Yingkai Zhang
Journal:  J Phys Chem B       Date:  2007-03-22       Impact factor: 2.991

3.  Rubisco in complex with Rubisco large subunit methyltransferase.

Authors:  Stefan Raunser; Roberta Magnani; Zhong Huang; Robert L Houtz; Raymond C Trievel; Pawel A Penczek; Thomas Walz
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-10       Impact factor: 11.205

Review 4.  The promise and failures of epigenetic therapies for cancer treatment.

Authors:  Pasano Bojang; Kenneth S Ramos
Journal:  Cancer Treat Rev       Date:  2013-07-05       Impact factor: 12.111

Review 5.  Tailoring Proteins to Re-Evolve Nature: A Short Review.

Authors:  Angelica Jimenez-Rosales; Miriam V Flores-Merino
Journal:  Mol Biotechnol       Date:  2018-12       Impact factor: 2.695

6.  Biochemical reconstitution and phylogenetic comparison of human SET1 family core complexes involved in histone methylation.

Authors:  Stephen A Shinsky; Kelsey E Monteith; Susan Viggiano; Michael S Cosgrove
Journal:  J Biol Chem       Date:  2015-01-05       Impact factor: 5.157

7.  SET7/9 catalytic mutants reveal the role of active site water molecules in lysine multiple methylation.

Authors:  Paul A Del Rizzo; Jean-François Couture; Lynnette M A Dirk; Bethany S Strunk; Marijo S Roiko; Joseph S Brunzelle; Robert L Houtz; Raymond C Trievel
Journal:  J Biol Chem       Date:  2010-08-01       Impact factor: 5.157

8.  Identification of family determining residues in Jumonji-C lysine demethylases: A sequence-based, family wide classification.

Authors:  Patrick Slama
Journal:  Proteins       Date:  2016-03

9.  Dominant alleles identify SET domain residues required for histone methyltransferase of Polycomb repressive complex 2.

Authors:  Preeti Joshi; Elizabeth A Carrington; Liangjun Wang; Carrie S Ketel; Ellen L Miller; Richard S Jones; Jeffrey A Simon
Journal:  J Biol Chem       Date:  2008-08-08       Impact factor: 5.157

10.  Structural biology of human H3K9 methyltransferases.

Authors:  Hong Wu; Jinrong Min; Vladimir V Lunin; Tatiana Antoshenko; Ludmila Dombrovski; Hong Zeng; Abdellah Allali-Hassani; Valérie Campagna-Slater; Masoud Vedadi; Cheryl H Arrowsmith; Alexander N Plotnikov; Matthieu Schapira
Journal:  PLoS One       Date:  2010-01-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.